Remove Biosimilars Remove Communication Remove Diabetes
article thumbnail

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

Alvotech has moved one step closer to entering the Eylea (aflibercept 2 mg) biosimilar market, after a European Medicines Agency (EMA) panel recommended approval of its copycat biologic. Go deeper with GlobalData Reports LOA and PTSR Model - Aflibercept Biosimilar in Age Related Macular. CucuMberStudio via Shutterstock.

article thumbnail

Towards a healthier, more equitable and innovative Indian healthcare sector

Express Pharma

Establishing Centers of Excellence and leveraging artificial intelligence for pharma research can advance India’s capabilities in NCEs, biologics, and biosimilars, placing it at the forefront of global pharma innovation. Enable global competitiveness The MedTech sector aspires to reduce import dependence and become globally competitive.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

CMS should draw on lessons from previous transitions, including biosimilar coverage rollouts and site-of-care policy shifts, to avoid known implementation pitfalls. Even well-intentioned policies can create access disparities if communication and operational support are lacking.

article thumbnail

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Pharmacy Times

CPAs are essentially signed contracts that have formal agreements with well-defined scopes, which allow for collaboration and communication among health care professionals in areas lacking aspects of health care, according to Klepser. This is where collaborative practice agreements (CPAs) come in.

article thumbnail

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Pharmacy Times

Treatment is more of an art,” she added, describing HFpEF as a condition that often requires tinkering and frequent communication with the patient to get the treatments right.

article thumbnail

Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance

Pharmacy Times

Communicating with vaccine-hesitant parents: a narrative review. Trust, influence, and community: why pharmacists and pharmacies are central for addressing vaccine hesitancy. Causes of vaccine hesitancy in adults for the influenza and COVID-19 vaccines: a systematic literature review. Vaccines (Basel). 2022;10(9):1518. Acad Pediatr.

article thumbnail

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Pharmacy Times

The findings highlight that there remain communication gaps between oncology providers and patients and that opportunities exist for pharmacists to counsel newly diagnosed oncology patients on their fertility preservation options.